Pyxis Oncology is trading 5.02% up at $3.35, with no confirmed explanation identified for this session’s move.
- No new company-specific announcement, earnings release, regulatory decision, or analyst action dated September 22, 2026 was identified.
- The latest notable items were September 9 clinical data and a September 10 price-target increase, both stale catalysts.
- The Nasdaq is up 0.42% and the S&P 500 0.01%, offering limited support without clearly explaining the gain.